Table 1 Predicted HMO/HMO degradation product utilization phenotypes of strains in the study.

From: Priority effects shape the structure of infant-type Bifidobacterium communities on human milk oligosaccharides

  1. + = predicted utilizer (transporter, GH/catabolic enzyme genes are present) +* = predicted degrader (extracellular GH genes are present) - = predicted non-utilizer.
  2. Colours: green = consumes a sugar; light red = does not consume a sugar; NT = not tested.
  3. LNT Lacto-N-tetraose, LNnT Lacto-N-neotetraose, 2′-FL 2′-Fucosyllactose, 3-FL 3-Fucosyllactose, LDFT Lactodifucotetraose, LNFP Lacto-N-fucopentaose, Lac Lactose, LNB Lacto-N-biose I, Glc Glucose, Gal Galactose, GlcNAc N-Acetylglucosamine, Fuc Fucose.
Back to article page